We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Can Molson Coors (TAP) Counter Headwinds with Cost Savings?
Read MoreHide Full Article
Shares of Molson Coors Brewing Company (TAP - Free Report) have underperformed both the Zacks categorized Beverages–Alcoholic industry and the broader sector on a year-to-date basis, primarily due to continued decline in volumes and sluggish results since past two quarters. The stock declined 2.1% against the industry’s gain of 12.7%. Meanwhile, the Zacks categorized Consumer Staples sector, of which they are part of, gained 10.7%.
Let’s Delve Deeper
Molson Coors began 2017 on a dismal note and also posted lower-than-expected results for the second straight when it posted first-quarter 2017 results. In fact, a glimpse of the company’s past performance reveals that its earnings have missed the Zacks Consensus Estimate in three of the trailing four quarters, with an average miss of 22.6%. Also, its sales lagged the same in four of the past seven quarters.
Moreover, its sales and earnings declined year over year in the first quarter. While earnings were hurt by higher brand amortization expense, mix shift to higher-cost products and weaker volumes in the U.S. in the quarter, sales were affected by currency headwinds and soft sales in Europe and the U.S.
Notably, Molson Coors has been posting negative beer volumes in the U.S. and Canada for quite some time. In the U.S., the company witnessed declines due to declining labor participation rates and lower consumer confidence. Though economic conditions improved slightly, competition from outside the beer category remained challenging for the industry. In the first quarter, both the U.S. domestic sales-to-retailers volume (STRs) and domestic sales-to-wholesalers volume (STWs) declined 2% and 4%, respectively.
However, the Zacks Consensus Estimate of $2.10 for the second quarter remained stable over the last 30 days. Moving ahead, difficult economy and competitive pressure along with lower volumes and significant currency headwinds continues to remain major concerns.
On the contrary, Molson Coors has been undertaking restructuring initiatives to reduce overhead costs and boost profitability. Moving ahead, management plans to deliver more than $175 million as cost savings in 2017. Notably, this Zacks Rank #3 (Hold) company boasts a strong portfolio of well-established brands and consistently makes innovations to expand its market share.
Furthermore, the company is expanding global footprint and accelerating its international business through acquisitions. Whether these ongoing initiatives will be able to spark a turnaround in the company’s performance, is a wait-and-watch story.
Ollie's Bargain, with a long-term earnings growth rate of 17.1% has surged 56.8% in the last one year.
Energizer Holdings, with a long-term earnings growth rate of 9.8% has posted an average beat of 21.6% in the last four quarters.
Tupperware Brands, with a long-term earnings growth rate of 12% has posted an average beat of 6.6% in the last four quarters.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Can Molson Coors (TAP) Counter Headwinds with Cost Savings?
Shares of Molson Coors Brewing Company (TAP - Free Report) have underperformed both the Zacks categorized Beverages–Alcoholic industry and the broader sector on a year-to-date basis, primarily due to continued decline in volumes and sluggish results since past two quarters. The stock declined 2.1% against the industry’s gain of 12.7%. Meanwhile, the Zacks categorized Consumer Staples sector, of which they are part of, gained 10.7%.
Let’s Delve Deeper
Molson Coors began 2017 on a dismal note and also posted lower-than-expected results for the second straight when it posted first-quarter 2017 results. In fact, a glimpse of the company’s past performance reveals that its earnings have missed the Zacks Consensus Estimate in three of the trailing four quarters, with an average miss of 22.6%. Also, its sales lagged the same in four of the past seven quarters.
Moreover, its sales and earnings declined year over year in the first quarter. While earnings were hurt by higher brand amortization expense, mix shift to higher-cost products and weaker volumes in the U.S. in the quarter, sales were affected by currency headwinds and soft sales in Europe and the U.S.
Notably, Molson Coors has been posting negative beer volumes in the U.S. and Canada for quite some time. In the U.S., the company witnessed declines due to declining labor participation rates and lower consumer confidence. Though economic conditions improved slightly, competition from outside the beer category remained challenging for the industry. In the first quarter, both the U.S. domestic sales-to-retailers volume (STRs) and domestic sales-to-wholesalers volume (STWs) declined 2% and 4%, respectively.
However, the Zacks Consensus Estimate of $2.10 for the second quarter remained stable over the last 30 days. Moving ahead, difficult economy and competitive pressure along with lower volumes and significant currency headwinds continues to remain major concerns.
On the contrary, Molson Coors has been undertaking restructuring initiatives to reduce overhead costs and boost profitability. Moving ahead, management plans to deliver more than $175 million as cost savings in 2017. Notably, this Zacks Rank #3 (Hold) company boasts a strong portfolio of well-established brands and consistently makes innovations to expand its market share.
Furthermore, the company is expanding global footprint and accelerating its international business through acquisitions. Whether these ongoing initiatives will be able to spark a turnaround in the company’s performance, is a wait-and-watch story.
Stocks that Warrant a Look
Better-ranked stocks in the broader Consumer Staples sector include Ollie's Bargain Outlet Holdings, Inc. (OLLI - Free Report) , Energizer Holdings, Inc. (ENR - Free Report) and Tupperware Brands Corporation (TUP - Free Report) , carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Ollie's Bargain, with a long-term earnings growth rate of 17.1% has surged 56.8% in the last one year.
Energizer Holdings, with a long-term earnings growth rate of 9.8% has posted an average beat of 21.6% in the last four quarters.
Tupperware Brands, with a long-term earnings growth rate of 12% has posted an average beat of 6.6% in the last four quarters.
More Stock News: 8 Companies Verge on Apple-Like Run
Did you miss Apple's 9X stock explosion after they launched their iPhone in 2007? Now 2017 looks to be a pivotal year to get in on another emerging technology expected to rock the market. Demand could soar from almost nothing to $42 billion by 2025. Reports suggest it could save 10 million lives per decade which could in turn save $200 billion in U.S. healthcare costs.
A bonus Zacks Special Report names this breakthrough and the 8 best stocks to exploit it. Like Apple in 2007, these companies are already strong and coiling for potential mega-gains. Click to see them right now >>